Key statistics
On Thursday, Regenxbio Inc (RGNX:NSQ) closed at 12.50, 19.16% above the 52 week low of 10.49 set on Jul 08, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 12.99 |
---|---|
High | 13.15 |
Low | 12.42 |
Bid | 11.90 |
Offer | 13.88 |
Previous close | 12.53 |
Average volume | 470.20k |
---|---|
Shares outstanding | 49.42m |
Free float | 45.82m |
P/E (TTM) | -- |
Market cap | 617.79m USD |
EPS (TTM) | -5.27 USD |
Data delayed at least 15 minutes, as of Sep 19 2024 21:00 BST.
More ▼
- REGENXBIO Appoints Mitchell Chan as Chief Financial Officer
- REGENXBIO Announces Positive Data from Pivotal Dose Level of RGX-121 Demonstrating Long-Term Systemic Effect
- REGENXBIO to Participate in Upcoming Investor Conferences
- REGENXBIO Announces Presentation at the Society for the Study of Inborn Errors of Metabolism (SSIEM) 2024 Annual Symposium
- REGENXBIO to Participate in the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference
- REGENXBIO Reports Second Quarter 2024 Financial Results and Recent Operational Highlights
- REGENXBIO ANNOUNCES NEW POSITIVE DATA FROM AFFINITY DUCHENNE® TRIAL OF RGX-202
- REGENXBIO to Host Conference Call on August 1 to Discuss Second Quarter 2024 Financial Results and Recent Operational Highlights
- REGENXBIO Announces Expansion of AFFINITY DUCHENNE® Trial to Include a New Cohort of Younger Patients
More ▼